TiAB Vaginal Gel for vaginal atrophy and prevention of infections (Women’s Health - gynecology - vaginal atrophy)

TiAB vaginal gel combined components have a synergic activity in the treatment of vaginal symptoms in Genitourinary Syndrome in Menopause (GSM). Hyaluronic acid contributes to form a film on the vaginal mucosae creating the ideal environment to facilitate tissues reepithelization, the natural component genistein acts as antioxidant and radical scavenger while TiAB (a patented complex of titanium/silicium dioxide with covalently linked monovalent silver ions) contributes to the mucosae protection from external pathogens (virus, bacteria, fungi) and promotes the physiological healing contributing to the repair of those lesions associated with vaginal atrophy

Presentation: 7 5ml cannulas containing TiAB, sodium hyaluronate and genisteinCE Mark expiry date: 31/12/2028 under Eu Directive (MDR in progress)
IP protected